| Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum SP Weisberg, TJ Connors, Y Zhu, MR Baldwin, WH Lin, S Wontakal, ... Nature immunology 22 (1), 25-31, 2021 | 491 | 2021 |
| The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles B Boson, V Legros, B Zhou, E Siret, C Mathieu, FL Cosset, D Lavillette, ... Journal of Biological Chemistry 296, 2021 | 246 | 2021 |
| Nipah virus uses leukocytes for efficient dissemination within a host C Mathieu, C Pohl, J Szecsi, S Trajkovic-Bodennec, S Devergnas, ... Journal of virology 85 (15), 7863-7871, 2011 | 119 | 2011 |
| Protection against henipavirus infection by use of recombinant adeno-associated virus–vector vaccines A Ploquin, J Szécsi, C Mathieu, V Guillaume, V Barateau, KC Ong, ... The Journal of infectious diseases 207 (3), 469-478, 2013 | 95 | 2013 |
| Type I interferon signaling protects mice from lethal henipavirus infection KP Dhondt, C Mathieu, M Chalons, JM Reynaud, A Vallve, H Raoul, ... The Journal of infectious diseases 207 (1), 142-151, 2013 | 82 | 2013 |
| Nonstructural Nipah virus C protein regulates both the early host proinflammatory response and viral virulence C Mathieu, V Guillaume, VA Volchkova, C Pohl, F Jacquot, RY Looi, ... Journal of virology 86 (19), 10766-10775, 2012 | 81 | 2012 |
| A general strategy to endow natural fusion-protein-derived peptides with potent antiviral activity A Pessi, A Langella, E Capitò, S Ghezzi, E Vicenzi, G Poli, T Ketas, ... PLoS One 7 (5), e36833, 2012 | 79 | 2012 |
| A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis M Espi, X Charmetant, T Barba, C Mathieu, C Pelletier, L Koppe, ... Kidney international 101 (2), 390-402, 2022 | 72 | 2022 |
| Measles encephalitis: towards new therapeutics M Ferren, B Horvat, C Mathieu Viruses 11 (11), 1017, 2019 | 72 | 2019 |
| Fatal measles virus infection prevented by brain-penetrant fusion inhibitors JC Welsch, A Talekar, C Mathieu, A Pessi, A Moscona, B Horvat, ... Journal of virology 87 (24), 13785-13794, 2013 | 65 | 2013 |
| HSP90 chaperoning in addition to phosphoprotein required for folding but not for supporting enzymatic activities of measles and Nipah virus L polymerases LM Bloyet, J Welsch, F Enchery, C Mathieu, S De Breyne, B Horvat, ... Journal of virology 90 (15), 6642-6656, 2016 | 58 | 2016 |
| Lethal Nipah virus infection induces rapid overexpression of CXCL10 C Mathieu, V Guillaume, A Sabine, KC Ong, KT Wong, C Legras-Lachuer, ... PLoS One 7 (2), e32157, 2012 | 57 | 2012 |
| Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19 SP Weisberg, T Connors, Y Zhu, M Baldwin, WH Lin, S Wontakal, ... Medrxiv, 2020.07. 12.20151068, 2020 | 56 | 2020 |
| Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides C Mathieu, D Huey, E Jurgens, JC Welsch, I DeVito, A Talekar, B Horvat, ... Journal of virology 89 (2), 1143-1155, 2015 | 56 | 2015 |
| Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides C Mathieu, MT Augusto, S Niewiesk, B Horvat, LM Palermo, G Sanna, ... Scientific reports 7 (1), 43610, 2017 | 51 | 2017 |
| Measles fusion machinery is dysregulated in neuropathogenic variants EM Jurgens, C Mathieu, LM Palermo, D Hardie, B Horvat, A Moscona, ... MBio 6 (1), 10.1128/mbio. 02528-14, 2015 | 51 | 2015 |
| Fusion inhibitory lipopeptides engineered for prophylaxis of Nipah virus in primates C Mathieu, M Porotto, TN Figueira, B Horvat, A Moscona The Journal of Infectious Diseases 218 (2), 218-227, 2018 | 46 | 2018 |
| In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence TN Figueira, LM Palermo, AS Veiga, D Huey, CA Alabi, NC Santos, ... Journal of virology 91 (1), 10.1128/jvi. 01554-16, 2017 | 45 | 2017 |
| Henipavirus pathogenesis and antiviral approaches C Mathieu, B Horvat Expert Review of Anti-infective Therapy 13 (3), 343-354, 2015 | 44 | 2015 |
| Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection M Ferren, V Favède, D Decimo, M Iampietro, NAP Lieberman, JL Weickert, ... Nature Communications 12 (1), 5809, 2021 | 42 | 2021 |
